Skip to main content

Posts

Showing posts with the label pandemic influenza

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 18 '26)

  Antiviral Res LEEKHA A, Reichel K, Hurst B, Varadarajan N, et al Therapeutic intranasal delivery of NanoSTING provides broad protection against seasonal and highly pathogenic influenza strains. Antiviral Res. 2026 Jan 14:106342. doi: 10.1016/j.antiviral.2026.106342. PubMed           Abstract available BMJ MARTIN DS, Doidge JC, Gould D, Shahid T, et al The impact of skin tone on performance of pulse oximeters used by NHS England COVID Oximetry @home scheme: measurement and diagnostic accuracy study. BMJ. 2026;392:e085535. PubMed           Abstract available Drug Saf PALMER M, Seekins D, Avigan M, Marcinak J, et al The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative. Drug Saf. 2026;49:9-25. PubMed        ...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 11 '26)

  Ann Intern Med TERAN-PLASENCIA JM, Kalil AC In adults hospitalized with acute HF, predischarge influenza vaccination reduced a composite of mortality or readmission at 1 y. Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-04799. PubMed           Abstract available TONG SYC, Gibney KB In older adults, high- vs. standard-dose influenza vaccine reduced hospitalization for influenza or pneumonia. Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-05209. PubMed           Abstract available Arch Virol YAN Y, Pan Z, Mao L, Niu P, et al Genome surveillance of SARS-CoV-2 Omicron XBB subvariants in Wuhan in June 2023. Arch Virol. 2026;171:38. PubMed           Abstract available Biochem Biophys Res Commun HUANG A, Li C, Wu H, Sun W, et al Development of human single-domain antibodies against influenza based on NA-targeting IgG. Biochem Biophys Res Commun. 2026;798:153238...

Adjuvanted #influenza #vaccination increases pre-existing #H5N1 cross-reactive #antibodies

  Abstract Highly pathogenic H5N1 avian influenza viruses of clade 2.3.4.4b cause sporadic human infections and currently raise concerns about a new influenza pandemic . Heterogeneities in disease severity have been observed in the past and are reported among infected farm workers in the United States . These may be attributed to differences in pre-existing H5N1 cross-reactive antibodies . In this study, we characterize H5N1 cross-reactive antibody landscapes in the current population (#NCT05794412 and #NCT01022905) and assess the effect of AS03-adjuvanted pandemic H1N1 and non-adjuvanted seasonal influenza vaccination on H5N1 cross-neutralizing and IgG antibody titers targeting a range of influenza virus-derived antigens. We detect H5N1 cross-neutralizing antibodies using a vesicular stomatitis virus-based pseudovirus system that correlate well with antibodies inhibiting the spread of authentic H5N1 viruses, anti-group 1 hemagglutinin stalk and anti-trimeric hemagglutinin antibodi...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 3 '26)

  BMC Pediatr CHEN Y, Wang Y, Tao X, Zhou M, et al Pediatric necrotizing pneumonia caused by mixed infection with influenza A virus and Panton-Valentine Leucocidin-producing Staphylococcus aureus: case report and literature review. BMC Pediatr. 2025 Dec 24. doi: 10.1186/s12887-025-06410. PubMed           Abstract available Eur J Epidemiol OSTERGREN OM, Counil E, Karimi A, Fall T, et al Who got tested and who got sick? Sociodemographic inequalities in COVID-19 testing and hospitalization among 1.48 million individuals in Sweden. Eur J Epidemiol. 2025;40:1431-1439. PubMed           Abstract available J Immunol ABE K, Holmes TH, Nguyen TT, Kim-Schulze S, et al Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study. J Immunol. 2025;214:3310-3320. PubMed           Abstract available OSUAGWU AE, Payne M, Bosch J, Mbony...

Enhanced #genome #replication activity of pandemic #H1N1 #influenza A virus through PA #mutations

  ABSTRACT The 2009 pandemic H1N1 (pH1N1) influenza A virus (IAV) is a reassortant virus with two polymerase components, PA and PB2, originating from avian IAV . Avian IAV polymerase does not function efficiently in mammalian cells without host-adaptive mutations . The mechanism by which pH1N1 replicates in human hosts is not fully elucidated , as pH1N1 does not contain the host-adaptive PB2 E627K mutation required for species-specific interaction with ANP32 , which facilitates replicase (polymerase oligomer) formation. Our previous research revealed that mutations in PA played a key role in mammalian host adaptation of pH1N1. These mutations were found in two separate domains of PA, the C-terminal (CTD) and N-terminal domains (NTD). We reported that the NTD mutations increase the expression of NP through enhanced association of GRSF1 with the mRNA transcripts. However, the role of CTD mutations, which are located at the interface of the polymerase oligomers , has not been elucidat...

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Dec. 21 '25)

  Antimicrob Agents Chemother LEONARD VHJ, Vidales DB, Taft BR, Hesse MJ, et al Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization. Antimicrob Agents Chemother. 2025 Dec 19:e0114925. doi: 10.1128/aac.01149. PubMed           Abstract available Arch Virol BEDAIR NM, Sakr MA, Mourad A, Eissa N, et al Genetic characterization of highly pathogenic avian influenza A/H5N8 virus isolated from commercial poultry farms in Egypt reveals zoonotic potential. Arch Virol. 2025;171:29. PubMed           Abstract available Biochemistry WESTMAN H, Hammarstrom P, Nystrom S SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis. Biochemistry. 2025;64:4818-4829. PubMed           Abstract available Epidemiol Infect STADHOUDERS L, Hoogteijling EM, Duijts L, Lebon A, et al Trends in a...

Immunological and virological #questions for #H5N1 #pandemic emergence

  Abstract Zoonotic spillover of influenza A viruses into humans has repeatedly triggered pandemics throughout history. Since their emergence in the 1990s, H5N1 influenza viruses have significantly expanded their geographical range and host species , raising global concern about the potential for sustained human-to-human transmission . In this review , we examine the virological characteristics of currently circulating H5N1 strains, key molecular barriers limiting their spread among humans, and critical areas of future research to mitigate the ongoing H5N1 panzootic and prevent future pandemics. Source:  Link:  https://academic.oup.com/immunohorizons/article/9/SI/vlaf062/8381786 ____

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Dec. 15 '25)

  Biochem Biophys Res Commun HU J, Li J, You W, Liu L, et al Disruption of the local vRNA structure at the end of HA encoding region interferes with the selective packaging of influenza A virus genome. Biochem Biophys Res Commun. 2025;795:153082. PubMed           Abstract available BANGARU MLY, Raghavendra NK Helix alpha1 of human ACE2 mimics dsDNA and Spike of SARS-CoV-2 binds DNA. Biochem Biophys Res Commun. 2025;793:153020. PubMed           Abstract available Cell WASDIN PT, Johnson NV, Janke AK, Held S, et al Generation of antigen-specific paired-chain antibodies using large language models. Cell. 2025;188:7206-7221. PubMed           Abstract available YAN L, Huang Y, Liu Y, Ge J, et al Structural basis for the concurrence of template recycling and RNA capping in SARS-CoV-2. Cell. 2025;188:7194-7205. PubMed           Abs...